Self-management support for insulin therapy in type 2 diabetes

被引:47
作者
Funnell, MM [1 ]
Kruger, DF [1 ]
Spencr, M [1 ]
机构
[1] Michigan Diabet Res & Training Ctr, Ann Arbor, MI 48109 USA
关键词
D O I
10.1177/014572170403000220
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE The purpose of this article is to describe the self-management support that can be provided by diabetes educators for type 2 diabetes patients who are transitioning from therapy with oral hypoglycemic agents to insulin. METHODS The role of the diabetes educator in patient education and self-management support during all aspects of insulin therapy is discussed. Phases during which support may be especially important include the decision-making process, initiation, and maintenance. RESULTS Although some patients make the decision fairly easily, the introduction of insulin therapy is likely to raise many issues and questions for many type 2 diabetes patients. The more reluctant patients may experience psychological insulin resistance, a syndrome where insulin therapy is viewed as a threat or failure, which can affect health professionals as well. The diabetes educator can provide support and approaches to bel. p diminish this resistance and make the transition to insulin therapy easier and more effective for patients with type 2 diabetes. CONCLUSIONS Education and ongoing self-management support are needed for informed decision making and the initiation and maintenance Of insulin therapy. Therefore, diabetes educators have a critical role to play during both the decision-making process and the safe transition to insulin therapy.
引用
收藏
页码:274 / 280
页数:7
相关论文
共 24 条
[11]  
Leslie C., 1994, Diabetes Spectr., V7, P52
[12]   Before oral agents fail: the case for starting insulin early [J].
Marre, M .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (Suppl 3) :S25-S30
[13]   Self-management education for adults with type 2 diabetes - A meta-analysis of the effect on glycemic control [J].
Norris, SL ;
Lau, J ;
Smith, SJ ;
Schmid, CH ;
Engelgau, MM .
DIABETES CARE, 2002, 25 (07) :1159-1171
[14]   Quality of life following a change in therapy for diabetes mellitus [J].
Pibernik-Okanovic, M ;
Szabo, S ;
Metelko, Z .
PHARMACOECONOMICS, 1998, 14 (02) :201-207
[15]  
Rosenstock J, 2002, DIABETES, V51, pA482
[16]   Psychological issues and treatments for people with diabetes [J].
Rubin, RR ;
Peyrot, M .
JOURNAL OF CLINICAL PSYCHOLOGY, 2001, 57 (04) :457-478
[17]  
Snoek F, 2001, DIABETES VOICE, V46, P26
[18]  
SPOLLETT GR, 2003, PRACTICAL DIABETOL, V21, P33
[19]   Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus - A randomized, controlled, double-blind trial [J].
Testa, MA ;
Simonson, DC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17) :1490-1496
[20]   Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].
Turner, RC ;
Holman, RR ;
Cull, CA ;
Stratton, IM ;
Matthews, DR ;
Frighi, V ;
Manley, SE ;
Neil, A ;
McElroy, K ;
Wright, D ;
Kohner, E ;
Fox, C ;
Hadden, D ;
Mehta, Z ;
Smith, A ;
Nugent, Z ;
Peto, R ;
Adlel, AI ;
Mann, JI ;
Bassett, PA ;
Oakes, SF ;
Dornan, TL ;
Aldington, S ;
Lipinski, H ;
Collum, R ;
Harrison, K ;
MacIntyre, C ;
Skinner, S ;
Mortemore, A ;
Nelson, D ;
Cockley, S ;
Levien, S ;
Bodsworth, L ;
Willox, R ;
Biggs, T ;
Dove, S ;
Beattie, E ;
Gradwell, M ;
Staples, S ;
Lam, R ;
Taylor, F ;
Leung, L ;
Carter, RD ;
Brownlee, SM ;
Fisher, KE ;
Islam, K ;
Jelfs, R ;
Williams, PA ;
Williams, FA ;
Sutton, PJ .
LANCET, 1998, 352 (9131) :837-853